|
RGMB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.438900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.420800E-04 |
| Normal-vs-Stage2 |
6.474100E-02 |
| Normal-vs-Stage3 |
8.624800E-01 |
| Normal-vs-Stage4 |
9.705000E-01 |
| Stage1-vs-Stage2 |
7.490600E-01 |
| Stage1-vs-Stage3 |
1.093230E-01 |
| Stage1-vs-Stage4 |
2.348400E-01 |
| Stage2-vs-Stage3 |
2.501400E-01 |
| Stage2-vs-Stage4 |
2.677800E-01 |
| Stage3-vs-Stage4 |
8.954000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.481700E-03 |
| Normal-vs-AfricanAmerican |
1.456050E-02 |
| Normal-vs-Asian |
1.677790E-01 |
| Caucasian-vs-AfricanAmerican |
8.940200E-01 |
| Caucasian-vs-Asian |
9.395200E-01 |
| AfricanAmerican-vs-Asian |
9.638400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.444200E-04 |
| Normal-vs-Female |
7.306200E-01 |
| Male-vs-Female |
1.804090E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.143500E-02 |
| Normal-vs-Extreme_Weight |
2.336500E-03 |
| Normal-vs-Obese |
1.348630E-01 |
| Normal-vs-Extreme_Obese |
5.635600E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.118200E-01 |
| Normal_Weight-vs-Obese |
5.957400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.465800E-02 |
| Extreme_Weight-vs-Obese |
1.459600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.239600E-01 |
| Obese-vs-Extreme_Obese |
1.865540E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.802200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.159900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.010400E-04 |
| Normal-vs-Age(81-100Yrs) |
3.718300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.936200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.273390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.394600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.555870E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.535750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.945400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.822300E-03 |
| Normal-VS-Type2 PRCC |
9.93390000000316E-05 |
| Normal-VS-KIRP CIMP |
1.119020E-01 |
| Normal-VS-Unclassified PRCC |
7.393800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.525580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.311900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.739400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.161900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.595200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.436100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.15069999587314E-08 |
| Normal-vs-N1 |
4.908000E-01 |
| Normal-vs-N2 |
4.286600E-01 |
| N0-vs-N1 |
6.355400E-03 |
| N0-vs-N2 |
1.460620E-01 |
| N1-vs-N2 |
6.185800E-01 |
|
|
